Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-14-002530
Filing Date
2014-01-15
Accepted
2014-01-15 17:13:49
Documents
1
Period of Report
2014-01-15

Document Format Files

Seq Description Document Type Size
1 rrd399911.html 4  
1 rrd399911.xml 4 8611
  Complete submission text file 0001181431-14-002530.txt   10537
Mailing Address
Business Address 1119 ST PAUL STREET BALTIMORE MD 21202 4102440115
NEW ENTERPRISE ASSOCIATES 10 L P (Reporting) CIK: 0001132326 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36177 | Film No.: 14530408

Mailing Address 1119 ST PAUL STREET BALTIMORE MD 21202
Business Address 1119 ST PAUL STREET BALTIMORE MD 21202 4102440115
NEA PARTNERS 10 L P (Reporting) CIK: 0001236049 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36177 | Film No.: 14530407

Mailing Address 401 PROFESSIONAL DRIVE, SUITE 250 GAITHERSBURG MD 20879
Business Address 401 PROFESSIONAL DRIVE, SUITE 250 GAITHERSBURG MD 20879 240-243-1201
GLYCOMIMETICS INC (Issuer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations